CathVision to Showcase Innovations at AF Symposium, Present New Science

Trending...
COPENHAGEN, Denmark, Jan. 15, 2025 ~ CathVision, a renowned leader in advanced electrophysiology (EP) solutions, has announced its participation in the upcoming AF Symposium in Boston this January. The company is known for its innovative technology and strong dedication to advancing EP labs globally, making it an exciting addition to the event.

The AF Symposium is a highly anticipated global event focused on managing cardiac arrhythmias. Visitors to the CathVision booth will have the opportunity to explore the latest advancements in the ECGenius System. This system is designed to provide physicians with high-quality cardiac signal data and optimized workflows, ultimately enhancing patient care.

Attendees will also have the chance to engage with CathVision representatives and discuss their latest research and development efforts. This includes upcoming trials such as unipolar signal analysis for pulsed-field ablation and automated measures for conduction system pacing.

More on Boston Chron
One of the highlights of CathVision's participation at the AF Symposium will be their presentation of new scientific research in collaboration with New York University (NYU) Langone Health. The study, led by Dr. Alexander Kushnir and Dr. Larry Chinitz, showcases the capabilities of CathVision's technology in providing deeper clinical insights, automating measurements, and displaying information in innovative ways.

According to Dr. Kushnir, "The goal of a cardiac ablation procedure is to specifically target the arrhythmia circuit. Entrainment mapping is a critical tool that is frequently underutilized due to challenges with implementing and interpreting the technique." He further explains that their work with CathVision has led to the development of cutting-edge entrainment tools designed to help physicians detect and entrain reentrant arrhythmias and identify optimal ablation targets.

The findings from this study reinforce CathVision's commitment to advancing the field of electrophysiology and improving patient outcomes. The company looks forward to further studying the power of their technology in prospective trials.

With its participation at the AF Symposium, CathVision continues to solidify its position as a leader in the EP industry and a driving force in advancing EP labs globally. Attendees can expect to be impressed by the company's latest accomplishments and groundbreaking technology.
Filed Under: Business

Show All News | Report Violation

0 Comments

Latest on Boston Chron